These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3908499)

  • 21. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandins: effects on the gastrointestinal tract.
    Robert A
    Clin Physiol Biochem; 1984; 2(2-3):61-9. PubMed ID: 6386280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric cytoprotection by epidermal growth factor. Role of endogenous prostaglandins and DNA synthesis.
    Konturek SJ; Radecki T; Brzozowski T; Piastucki I; Dembiński A; Dembińska-Kieć A; Zmuda A; Gryglewski R; Gregory H
    Gastroenterology; 1981 Sep; 81(3):438-43. PubMed ID: 7018988
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mucosal lesions associated with antiphlogistics--treatment and prevention].
    Aabakken L; Osnes M
    Tidsskr Nor Laegeforen; 1992 May; 112(13):1705-7. PubMed ID: 1509428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin-induced gastroduodenal injury and its prevention by prostaglandins.
    Cohen MM
    Postgrad Med J; 1988; 64 Suppl 1():12-4. PubMed ID: 3047723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term changes in Helicobacter pylori gastritis and bulbitis during and after 2 weeks of treatment with omeprazole and amoxicillin in duodenal ulcer patients.
    Plein K; Madisch A; Stolte M; Hotz J
    Z Gastroenterol; 2001 Jul; 39(7):503-10. PubMed ID: 11505330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of the gastroduodenal mucosa by prostaglandins.
    Johansson C; Aly A; Befrits R; Smedfors B; Uribe A
    Scand J Gastroenterol Suppl; 1985; 110():41-8. PubMed ID: 3895394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International symposium on the recent advances in gastrointestinal cytoprotection. September 30-October 1, 1983, Pécs, Hungary.
    Acta Physiol Hung; 1984; 64(3-4):199-494. PubMed ID: 6532114
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prostaglandin derivatives and antacids in the treatment and prevention of gastroduodenal lesions].
    Miederer SE
    Dtsch Med Wochenschr; 1992 Nov; 117(46):1759-63. PubMed ID: 1425296
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the symptomatic clinical efficacy of ranitidine in benign gastroduodenal pathology].
    Rizzi B; Villa E; Di Sclafani E; Terni E; Proserpio L; Bonfanti R; Komla-Ebri K
    Clin Ter; 1985 Jun; 113(6):447-55. PubMed ID: 4028651
    [No Abstract]   [Full Text] [Related]  

  • 31. Gastroduodenal endoscopic-histologic correlation in pediatric patients.
    Black DD; Haggitt RC; Whitington PF
    J Pediatr Gastroenterol Nutr; 1988; 7(3):353-8. PubMed ID: 3385547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of a prostaglandin derivative in the treatment of gastroduodenal ulcer and gastroduodenitis].
    Germiniani R; Fichera G; Siardi C; Biolchi S; Zennaro F
    Minerva Dietol Gastroenterol; 1987; 33(2):169-80. PubMed ID: 3627525
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and safety of pirenzepine in peptic ulcer and in non ulcerous gastroduodenal diseases. A multicentre controlled clinical trial.
    Giorgi-Conciato M; Daniotti S; Ferrari PA; Gaetani M; Petrin G; Sala P; Valentini P
    Scand J Gastroenterol Suppl; 1982; 81():1-41. PubMed ID: 6221398
    [No Abstract]   [Full Text] [Related]  

  • 34. [Local factors in the pathogenesis of peptic ulcer].
    Grigor'ev PIa; Isakov VA; Iakovenko EP
    Klin Med (Mosk); 1988 May; 66(5):25-30. PubMed ID: 3047490
    [No Abstract]   [Full Text] [Related]  

  • 35. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 36. Simultaneous measurement of in vitro gastroduodenal prostaglandin E2 synthesis and degradation in peptic ulcer disease.
    Crampton JR; Gibbons LC; Rees WD
    Scand J Gastroenterol; 1987 May; 22(4):425-30. PubMed ID: 3474773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of arachidonic acid metabolites in gastrointestinal homeostasis. Biochemical, histological and clinical gastrointestinal effects.
    Isselbacher KJ
    Drugs; 1987; 33 Suppl 1():38-46. PubMed ID: 2885170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptic disease in paediatric patients: a diagnostic and therapeutic contribution.
    Deganello A; Tamassia G; Gaburro D
    Drugs Exp Clin Res; 1990; 16(2):75-83. PubMed ID: 2401189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A histological study of the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the gastric and duodenal mucosa.
    Moghal N; Jafarey NA
    J Pak Med Assoc; 1989 Nov; 39(11):287-90. PubMed ID: 2516535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.